{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:35:07Z","timestamp":1782146107517,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41590-025-02265-w","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T09:02:38Z","timestamp":1756717358000},"page":"1712-1725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pre-TCR-targeted immunotherapy for T cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-1022","authenticated-orcid":false,"given":"Patricia","family":"Fuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-132X","authenticated-orcid":false,"given":"Marina","family":"Garc\u00eda-Peydr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Alcain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Cela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-7901","authenticated-orcid":false,"given":"Claudia","family":"Cifuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Torrebadell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Isola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Cam\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-6973","authenticated-orcid":false,"given":"Manuel","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7820-1070","authenticated-orcid":false,"given":"Balbino","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-0373","authenticated-orcid":false,"given":"Mar\u00eda L.","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"2265_CR1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui, C. H., Robison, L. L. & Look, A. T. Acute lymphoblastic leukaemia. Lancet 371, 1030\u20131043 (2008).","journal-title":"Lancet"},{"key":"2265_CR2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","volume":"29","author":"C-H Pui","year":"2011","unstructured":"Pui, C. -H., Carroll, W. L., Meshinchi, S. & Arceci, R. J. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J. Clin. Oncol. 29, 551\u2013565 (2011).","journal-title":"J. Clin. Oncol."},{"key":"2265_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.13142","volume":"168","author":"R Sutton","year":"2015","unstructured":"Sutton, R. et al. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Br. J. Haematol. 168, 395\u2013404 (2015).","journal-title":"Br. J. Haematol."},{"key":"2265_CR4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","volume":"126","author":"MR Litzow","year":"2015","unstructured":"Litzow, M. R. & Ferrando, A. A. How I treat T-cell acute lymphoblastic leukemia in adults. Blood 126, 833\u2013841 (2015).","journal-title":"Blood"},{"key":"2265_CR5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2006","unstructured":"Fielding, A. K. et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 109, 944\u2013950 (2006).","journal-title":"Blood"},{"key":"2265_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.20110105","volume":"208","author":"E Clappier","year":"2011","unstructured":"Clappier, E. et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J. Exp. Med. 208, 653\u2013661 (2011).","journal-title":"J. Exp. Med."},{"key":"2265_CR7","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1080\/10428194.2019.1605071","volume":"60","author":"H Rafei","year":"2019","unstructured":"Rafei, H., Kantarjian, H. M. & Jabbour, E. J. Recent advances in the treatment of acute lymphoblastic leukemia. Leuk. Lymphoma 60, 2606\u20132621 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"2265_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1509277","volume":"375","author":"HM Kantarjian","year":"2016","unstructured":"Kantarjian, H. M. et al. Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. New Engl. J. Med. 375, 740\u2013753 (2016).","journal-title":"New Engl. J. Med."},{"key":"2265_CR9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2265_CR10","doi-asserted-by":"crossref","unstructured":"Scherer, L. D., Brenner, M. K. & Mamonkin, M. Chimeric antigen receptors for T-cell malignancies. Front. Oncol. 9, 126 (2019).","DOI":"10.3389\/fonc.2019.00126"},{"key":"2265_CR11","doi-asserted-by":"crossref","unstructured":"Bay\u00f3n-Calder\u00f3n, F., Toribio, M. L. & Gonz\u00e1lez-Garc\u00eda, S. Facts and challenges in immunotherapy for T-cell acute lymphoblastic leukemia. Int. J. Mol. Sci. 21, 7685 (2020).","DOI":"10.3390\/ijms21207685"},{"key":"2265_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","volume":"16","author":"LD Notarangelo","year":"2016","unstructured":"Notarangelo, L. D., Kim, M. -S., Walter, J. E. & Lee, Y. N. Human RAG mutations: biochemistry and clinical implications. Nat. Rev. Immunol. 16, 234\u2013246 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2265_CR13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver, L. & Ferrando, A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat. Rev. Cancer 16, 494\u2013507 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2265_CR14","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene, M. C. et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9, 1783\u20131786 (1995).","journal-title":"Leukemia"},{"key":"2265_CR15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","volume":"632","author":"P P\u00f6l\u00f6nen","year":"2024","unstructured":"P\u00f6l\u00f6nen, P. et al. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia. Nature 632, 1082\u20131091 (2024).","journal-title":"Nature"},{"key":"2265_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","volume":"10","author":"F Radtke","year":"1999","unstructured":"Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547\u2013558 (1999).","journal-title":"Immunity"},{"key":"2265_CR17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269\u2013271 (2004).","journal-title":"Science"},{"key":"2265_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","volume":"6","author":"C Grabher","year":"2006","unstructured":"Grabher, C., von Boehmer, H. & Look, A. T. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat. Rev. Cancer 6, 347\u2013359 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"2265_CR19","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2008-03-147587","volume":"112","author":"T Kindler","year":"2008","unstructured":"Kindler, T. et al. K-RasG12D-induced T-cell lymphoblastic lymphoma\/ leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors. Blood 112, 3373\u20133382 (2008).","journal-title":"Blood"},{"key":"2265_CR20","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood-2008-02-138172","volume":"113","author":"F Armstrong","year":"2009","unstructured":"Armstrong, F. et al. NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood 113, 1730\u20131740 (2009).","journal-title":"Blood"},{"key":"2265_CR21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2010-08-300343","volume":"118","author":"J Tatarek","year":"2011","unstructured":"Tatarek, J. et al. Notch1 inhibition targets the leukemia-initiating cells in a Tal1\/Lmo2 mouse model of T-ALL. Blood 118, 1579\u20131590 (2011).","journal-title":"Blood"},{"key":"2265_CR22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/ijms24021383","volume":"24","author":"ML Toribio","year":"2023","unstructured":"Toribio, M. L. & Gonz\u00e1lez-Garc\u00eda, S. Notch partners in the long journey of T-ALL pathogenesis. Int. J. Mol. Sci. 24, 1383 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2265_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1101\/gad.960702","volume":"16","author":"B Reizis","year":"2002","unstructured":"Reizis, B. & Leder, P. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16, 295\u2013300 (2002).","journal-title":"Genes Dev."},{"key":"2265_CR24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.7973703","volume":"266","author":"C Saint-Ruf","year":"1994","unstructured":"Saint-Ruf, C. et al. Analysis and expression of a cloned pre-T cell receptor gene. Science 266, 1208\u20131212 (1994).","journal-title":"Science"},{"key":"2265_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.184.2.519","volume":"184","author":"AR Ramiro","year":"1996","unstructured":"Ramiro, A. R., Trigueros, C., Marquez, C., San Millan, J. L. & Toribio, M. L. Regulation of pre-T cell receptor (pT alpha-TCR beta) gene expression during human thymic development. J. Exp. Med. 184, 519\u2013530 (1996).","journal-title":"J. Exp. Med."},{"key":"2265_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.immunol.15.1.433","volume":"15","author":"H von Boehmer","year":"1997","unstructured":"von Boehmer, H. & Fehling, H. J. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 15, 433\u2013452 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"2265_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/1074-7613(94)90102-3","volume":"1","author":"EC Dudley","year":"1994","unstructured":"Dudley, E. C., Petrie, H. T., Shah, L. M., Owen, M. J. & Hayday, A. C. T cell receptor \u03b2 chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1, 83\u201393 (1994).","journal-title":"Immunity"},{"key":"2265_CR28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/375795a0","volume":"375","author":"HJ Fehling","year":"1995","unstructured":"Fehling, H. J., Krotkova, A., Saint-Ruf, C. & von Boehmer, H. Crucial role of the pre-T-cell receptor \u03b1 gene in development of \u03b1\u03b2 but not \u03b3\u03b4 T cells. Nature 375, 795\u2013798 (1995).","journal-title":"Nature"},{"key":"2265_CR29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.188.8.1401","volume":"188","author":"C Trigueros","year":"1998","unstructured":"Trigueros, C. et al. Identification of a late stage of small noncycling pTalpha- pre-T cells as immediate precursors of T cell receptor alpha\/beta+ thymocytes. J. Exp. Med. 188, 1401\u20131412 (1998).","journal-title":"J. Exp. Med."},{"key":"2265_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.194.1.99","volume":"194","author":"D Allman","year":"2001","unstructured":"Allman, D. et al. Separation of Notch1 promoted lineage commitment and expansion\/transformation in developing T cells. J. Exp. Med. 194, 99\u2013106 (2001).","journal-title":"J. Exp. Med."},{"key":"2265_CR31","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1073\/pnas.062050599","volume":"99","author":"D Bellavia","year":"2002","unstructured":"Bellavia, D. et al. Combined expression of pT\u03b1 and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc. Natl Acad. Sci. USA 99, 3788\u20133793 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2265_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1897910","volume":"24","author":"M Tremblay","year":"2010","unstructured":"Tremblay, M. et al. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev. 24, 1093\u20131105 (2010).","journal-title":"Genes Dev."},{"key":"2265_CR33","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2006-09-048801","volume":"109","author":"NR Dos Santos","year":"2007","unstructured":"Dos Santos, N. R. et al. Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia. Blood 109, 3972\u20133981 (2007).","journal-title":"Blood"},{"key":"2265_CR34","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood-2007-01-066209","volume":"110","author":"M Fasseu","year":"2007","unstructured":"Fasseu, M. et al. p16INK4A tumor suppressor gene expression and CD3\u03f5 deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis. Blood 110, 2610\u20132619 (2007).","journal-title":"Blood"},{"key":"2265_CR35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood-2006-01-0143","volume":"108","author":"AF Campese","year":"2006","unstructured":"Campese, A. F. et al. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood 108, 305\u2013310 (2006).","journal-title":"Blood"},{"key":"2265_CR36","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2005-09-3551","volume":"107","author":"EJ Reschly","year":"2006","unstructured":"Reschly, E. J. et al. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 107, 4115\u20134121 (2006).","journal-title":"Blood"},{"key":"2265_CR37","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2002-08-2438","volume":"101","author":"V Asnafi","year":"2003","unstructured":"Asnafi, V. et al. Analysis of TCR, pT\u03b1, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101, 2693\u20132703 (2003).","journal-title":"Blood"},{"key":"2265_CR38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s43018-020-00167-4","volume":"2","author":"Y Gocho","year":"2021","unstructured":"Gocho, Y. et al. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nat Cancer 2, 284\u2013299 (2021).","journal-title":"Nat Cancer"},{"key":"2265_CR39","doi-asserted-by":"crossref","unstructured":"Courtois L. et al. Surface pT\u03b1 expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL. Blood 145, 2903\u20132913 (2025).","DOI":"10.1182\/blood.2024027982"},{"key":"2265_CR40","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI92981","volume":"128","author":"M Garc\u00eda-Peydr\u00f3","year":"2018","unstructured":"Garc\u00eda-Peydr\u00f3, M. et al. The NOTCH1\/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model. J. Clin. Invest. 128, 2802\u20132818 (2018).","journal-title":"J. Clin. Invest."},{"key":"2265_CR41","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.4049\/jimmunol.167.9.5106","volume":"167","author":"AR Ramiro","year":"2001","unstructured":"Ramiro, A. R. et al. Differential developmental regulation and functional effects on pre-TCR surface expression of human pTalpha(a) and pTalpha(b) spliced isoforms. J. Immunol. 167, 5106\u20135114 (2001).","journal-title":"J. Immunol."},{"key":"2265_CR42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear, W. S. et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283\u20132291 (1996).","journal-title":"J. Exp. Med."},{"key":"2265_CR43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645\u2013648 (1994).","journal-title":"Nature"},{"key":"2265_CR44","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco, G. et al. RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 26, 1627\u20131640 (2019).","journal-title":"Cell Rep."},{"key":"2265_CR45","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1074\/jbc.M204944200","volume":"278","author":"YR Carrasco","year":"2003","unstructured":"Carrasco, Y. R., Navarro, M. N. & Toribio, M. L. A role for the cytoplasmic tail of the pre-T cell receptor (TCR) alpha chain in promoting constitutive internalization and degradation of the pre-TCR. J. Biol. Chem. 278, 14507\u201314513 (2003).","journal-title":"J. Biol. Chem."},{"key":"2265_CR46","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.190.11.1647","volume":"190","author":"AM Michie","year":"1999","unstructured":"Michie, A. M., Trop, S., Wiest, D. L. & Z\u00fa\u00f1iga-Pfl\u00fccker, J. C. Extracellular signal\u2013regulated kinase (Erk) activation by the pre-T cell receptor in developing thymocytes in vivo. J. Exp. Med. 190, 1647\u20131656 (1999).","journal-title":"J. Exp. Med."},{"key":"2265_CR47","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1016\/j.febslet.2006.09.045","volume":"580","author":"HJ Hinton","year":"2006","unstructured":"Hinton, H. J., Clarke, R. G. & Cantrell, D. A. Antigen receptor regulation of phosphoinositide-dependent kinase 1 pathways during thymocyte development. FEBS Lett. 580, 5845\u20135850 (2006).","journal-title":"FEBS Lett."},{"key":"2265_CR48","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2007-06-094938","volume":"110","author":"MN Navarro","year":"2007","unstructured":"Navarro, M. N. et al. Identification of CMS as a cytosolic adaptor of the human pTalpha chain involved in pre-TCR function. Blood 110, 4331\u20134340 (2007).","journal-title":"Blood"},{"key":"2265_CR49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/87704","volume":"2","author":"I Aifantis","year":"2001","unstructured":"Aifantis, I., Gounari, F., Scorrano, L., Borowski, C. & von Boehmer, H. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-\u03baB and NFAT. Nat. Immunol. 2, 403\u2013409 (2001).","journal-title":"Nat. Immunol."},{"key":"2265_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/eji.201646522","volume":"47","author":"G Fu","year":"2017","unstructured":"Fu, G. et al. Phospholipase C\u03b31 is required for pre-TCR signal transduction and pre-T cell development. Eur. J. Immunol. 47, 74\u201383 (2017).","journal-title":"Eur. J. Immunol."},{"key":"2265_CR51","doi-asserted-by":"crossref","first-page":"ra115","DOI":"10.1126\/scisignal.2005650","volume":"7","author":"R Blanco","year":"2014","unstructured":"Blanco, R., Borroto, A., Schamel, W., Pereira, P. & Alarcon, B. Conformational changes in the T cell receptor differentially determine T cell subset development in mice. Sci. Signal. 7, ra115 (2014).","journal-title":"Sci. Signal."},{"key":"2265_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2017.03.021","volume":"446","author":"MK Verma","year":"2017","unstructured":"Verma, M. K. et al. A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo. J. Immunol. Methods 446, 47\u201353 (2017).","journal-title":"J. Immunol. Methods"},{"key":"2265_CR53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","volume":"18","author":"JZ Drago","year":"2021","unstructured":"Drago, J. Z., Modi, S. & Chandarlapaty, S. Unlocking the potential of antibody\u2013drug conjugates for cancer therapy. Nat. Rev. Clin. Oncol. 18, 327\u2013344 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2265_CR54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.193.9.1045","volume":"193","author":"YR Carrasco","year":"2001","unstructured":"Carrasco, Y. R. et al. An endoplasmic reticulum retention function for the cytoplasmic tail of the human pre-T cell receptor (TCR) alpha chain: potential role in the regulation of cell surface pre-TCR expression levels. J. Exp. Med. 193, 1045\u20131058 (2001).","journal-title":"J. Exp. Med."},{"key":"2265_CR55","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2018-10-882944","volume":"133","author":"D S\u00e1nchez-Mart\u00ednez","year":"2019","unstructured":"S\u00e1nchez-Mart\u00ednez, D. et al. Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia. Blood 133, 2291\u20132304 (2019).","journal-title":"Blood"},{"key":"2265_CR56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.2021013648","volume":"140","author":"PM Maciocia","year":"2022","unstructured":"Maciocia, P. M. et al. Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia. Blood 140, 25\u201337 (2022).","journal-title":"Blood"},{"key":"2265_CR57","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/2159-8290.CD-15-0675","volume":"6","author":"A Trinquand","year":"2016","unstructured":"Trinquand, A. et al. Triggering the TCR developmental checkpoint activates a therapeutically targetable tumor suppressive pathway in T-cell leukemia. Cancer Discov. 6, 972\u2013985 (2016).","journal-title":"Cancer Discov."},{"key":"2265_CR58","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07233-2","volume":"628","author":"TD Nichakawade","year":"2024","unstructured":"Nichakawade, T. D. et al. TRBC1-targeting antibody\u2013drug conjugates for the treatment of T cell cancers. Nature 628, 416\u2013423 (2024).","journal-title":"Nature"},{"key":"2265_CR59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI5201","volume":"103","author":"BF Haynes","year":"1999","unstructured":"Haynes, B. F. et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J. Clin. Invest. 103, 453\u2013460 (1999).","journal-title":"J. Clin. Invest."},{"key":"2265_CR60","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.2019000982","volume":"134","author":"S Gonz\u00e1lez-Garc\u00eda","year":"2019","unstructured":"Gonz\u00e1lez-Garc\u00eda, S. et al. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia. Blood 134, 2171\u20132182 (2019).","journal-title":"Blood"},{"key":"2265_CR61","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.leu.2404258","volume":"20","author":"T Palomero","year":"2006","unstructured":"Palomero, T. et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia 20, 1279\u20131287 (2006).","journal-title":"Leukemia"},{"key":"2265_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/srep20223","volume":"6","author":"J Ogando","year":"2016","unstructured":"Ogando, J. et al. Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients. Sci. Rep. 6, 20223 (2016).","journal-title":"Sci. Rep."},{"key":"2265_CR63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet, C. S. et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat. Methods 14, 521\u2013530 (2017).","journal-title":"Nat. Methods"},{"key":"2265_CR64","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1128\/MCB.20.20.7505-7515.2000","volume":"20","author":"JC Aster","year":"2000","unstructured":"Aster, J. C. et al. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1. Mol. Cell. Biol. 20, 7505\u20137515 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"2265_CR65","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2002-10-3241","volume":"102","author":"RS van Rijn","year":"2003","unstructured":"van Rijn, R. S. et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2\u2212\/\u2212 \u03b3c\u2212\/\u2212 double-mutant mice. Blood 102, 2522\u20132531 (2003).","journal-title":"Blood"},{"key":"2265_CR66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu, Y. & Smyth, G. K. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70\u201378 (2009).","journal-title":"J. Immunol. Methods"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02265-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02265-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:02:47Z","timestamp":1759183367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02265-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2265"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02265-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.29.596375","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}